Scientists put against cancer antigens in silicon nanoparticles. New approach tested on animals, the first results were positive, writes The Vaccine News Daily.
The release of drug activates the production of antibodies to a cancerous tumor. Choose the particles of active substance have similar effects, destroying cancer cells.
Silicone particles with the antigen HER2 provoke an immune response against tumors that produce a lot of HER2. Similar vaccines already exist, however, several disadvantages were not allowed to use them in practice. Now the drug is released at a different level, and not far off the first clinical trials of medicines.